Research on Long-Term Risk of VTE Sheds Light on Managing Chronic Condition
July 31, 2019 | Strategic Insights for Health System
Preview
What's the news. For patients with a first unprovoked venous thromboembolism (VTE) who completed at least three months of anticoagulant treatment, the risk of recurrence rose over time, reaching a 10% likelihood in the first year after treatment and 36% at 10 years, a July 24, 2019, study published in the BMJ says.